Stop Novartis' Attempt to Stifle Generic Production

March 15, 2012

The pharmaceutical company Novartis continues to put profits above people by challenging a seven-year old Indian court ruling that, if overturned, would have a devastating effect on access to generic forms of essential medicines, including HIV medications, in the developing world.

 

Related:

• The Long Battle Against TB
• Somali Refugees in Dadaab Struggle On
• Chasing Sleeping Sickness in Central Africa
• Maternal Health: An Ongoing Emergency

Tags: Access to Medicines

Podcast » A Doctor Returns to Somaliland

Video » Trans-Pacific Trade Pact: Hands Off Our Medicines

Open Letters » MSF Open Letter: Words Must be Turned into Humanitarian Action for Syrians

Slideshow » Surviving Two Years of Treatment for Drug-Resistant TB in Kyrgyzstan

Special Report » Healing Iraqis: The Challenges of Providing Mental Health Care in Iraq

About Us | Field News | Contact Us | Donate | MSF Offices Worldwide

This site is maintained by the U.S. section of Doctors Without Borders/Médecins Sans Frontières (MSF), an international independent medical humanitarian organization that delivers emergency aid to people affected by armed conflict, epidemics, natural and man-made disasters, and exclusion from health care. © 2013 MSF All rights reserved.

Doctors Without Borders is approved by the Internal Revenue Service as a 501 (C) (3) tax-exempt organization, and all donations are tax deductible to the extent provided by law. Doctors Without Borders Federal Identification Number (EIN) is 13-3433452.

MSF-USA Association | Copyright Statement | Privacy Policy

333 7th Avenue, New York, NY 10001-5004. Phone: 212-679-6800